Relapsed or Refractory Follicular Lymphoma or Mantle Cell Lymphoma
1 clinical trials · Condition
◉ Watch Relapsed or Refractory Follicular Lymphoma or Mantle Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| 131I-rituximab for Relapsed or Refractory Follicular or Mantle Cell Lymphoma (NCT01678417) | Korea Cancer Center Hospital | 2012-06-01 |
Track Relapsed or Refractory Follicular Lymphoma or Mantle Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.